Vimian Group AB (publ) (VIMGF)
VIMGF Stock Price Chart
Explore Vimian Group AB (publ) interactive price chart. Choose custom timeframes to analyze VIMGF price movements and trends.
VIMGF Company Profile
Discover essential business fundamentals and corporate details for Vimian Group AB (publ) (VIMGF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
IPO Date
22 Aug 2022
Employees
1.20K
Website
https://vimian.comCEO
Patrik Eriksson
Description
Vimian Group AB (publ) engages in the animal health business worldwide. It operates through Specialty Pharma, MedTech, Diagnostics, and Veterinary Services segments. The company offers proprietary diagnostics, prescription, and non-prescription treatments for preventive care and treatment of chronic conditions for companion animals under the Nextmune brand name; and molecular and immunodiagnostic solutions that are used by laboratories for veterinary specific applications with a focus on livestock and companion animal health markets under the Indical Bioscience brand name. It also provides procurement and tech-driven operations, such as online marketing, and education and HR, as well as a community for veterinary clinics through a membership-based platform under the VetFamily brand name; and orthopedic implants for veterinarians and universities under the Movora brand name. The company was incorporated in 2020 and is headquartered in Stockholm, Sweden.
VIMGF Financial Timeline
Browse a chronological timeline of Vimian Group AB (publ) corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 27 Apr 2026
Upcoming earnings on 12 Feb 2026
Upcoming earnings on 22 Oct 2025
Earnings released on 18 Jul 2025
EPS came in at $0.02 falling short of the estimated $0.03 by -48.01%, while revenue for the quarter reached $104.30M , beating expectations by +1.02%.
Earnings released on 29 Apr 2025
EPS came in at $0.01 falling short of the estimated $0.02 by -63.38%, while revenue for the quarter reached $107.50M , missing expectations by -2.18%.
Earnings released on 13 Feb 2025
EPS came in at $0.02 falling short of the estimated $0.02 by -6.89%, while revenue for the quarter reached $104.90M , beating expectations by +6.65%.
Earnings released on 24 Oct 2024
EPS came in at -$0.00 falling short of the estimated $0.02 by -117.45%, while revenue for the quarter reached $87.65M , missing expectations by -10.03%.
Earnings released on 15 Aug 2024
EPS came in at $0.01 falling short of the estimated $0.02 by -57.23%, while revenue for the quarter reached $90.99M , missing expectations by -5.55%.
Stock split effective on 13 May 2024
Shares were split 129 : 125 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 2 May 2024
EPS came in at $0.01 falling short of the estimated $0.03 by -72.53%, while revenue for the quarter reached $91.30M , missing expectations by -9.91%.
Earnings released on 15 Feb 2024
EPS came in at -$0.01 falling short of the estimated $0.01 by -229.42%, while revenue for the quarter reached $82.46M , missing expectations by -11.45%.
Earnings released on 30 Sept 2023
EPS came in at $0.02 surpassing the estimated $0.01 by +18.52%, while revenue for the quarter reached $79.88M , missing expectations by -2.73%.
Earnings released on 30 Jun 2023
EPS came in at $0.01 falling short of the estimated $0.01 by -46.86%, while revenue for the quarter reached $81.31M , missing expectations by -2.26%.
Earnings released on 31 Mar 2023
EPS came in at $0.01 falling short of the estimated $0.03 by -57.73%, while revenue for the quarter reached $88.08M , missing expectations by -3.58%.
Earnings released on 8 Mar 2023
EPS came in at -$0.04 falling short of the estimated $0.05 by -180.00%, while revenue for the quarter reached $75.46M , missing expectations by -4.37%.
Earnings released on 16 Nov 2022
EPS came in at $0.01 falling short of the estimated $0.03 by -66.67%, while revenue for the quarter reached $70.88M , beating expectations by +5.69%.
Earnings released on 24 Aug 2022
EPS came in at $0.04 surpassing the estimated $0.03 by +33.33%, while revenue for the quarter reached $67.03M , missing expectations by -1.91%.
Earnings released on 24 May 2022
EPS came in at $0.02 falling short of the estimated $0.03 by -33.33%, while revenue for the quarter reached $67.94M , missing expectations by -0.02%.
Earnings released on 9 Mar 2022
EPS came in at $0.02 falling short of the estimated $0.03 by -32.00%, while revenue for the quarter reached $48.70M , missing expectations by -6.47%.
Earnings released on 26 Nov 2021
EPS came in at $0.01 falling short of the estimated $0.02 by -50.00%, while revenue for the quarter reached $41.49M .
Earnings released on 25 Aug 2021
EPS came in at $0.02 , while revenue for the quarter reached $39.44M .
Earnings released on 11 Jun 2021
EPS came in at $2.16 , while revenue for the quarter reached $94.45M .
Earnings released on 31 Mar 2021
EPS came in at $0.02 , while revenue for the quarter reached $43.81M .
Earnings released on 30 Sept 2020
EPS came in at $0.01 , while revenue for the quarter reached $20.80M .
VIMGF Stock Performance
Access detailed VIMGF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.